CompletedPhase 3NCT00002839
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Jean-Louis Lefebvre, MDCentre Oscar Lambret
- Intervention
- cisplatin(drug)
- Enrollment
- 564 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 1996
Study locations (20)
- Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- CHR de Besancon - Hopital Jean Minjoz, Besançon, France
- Centre Regional Francois Baclesse, Caen, France
- Centre Hospitalier Universitaire de Dijon, Dijon, France
- Centre de Lutte Contre le Cancer, Georges-Francois Leclerc, Dijon, France
- Centre Oscar Lambret, Lille, France
- Centre Hospitalier Regional et Universitaire de Lille, Lille, France
- CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France
- Centre Antoine Lacassagne, Nice, France
- Hopital Charles Nicolle, Rouen, France
- Centre Alexis Vautrin, Vandœuvre-lès-Nancy, France
- Rambam Medical Center, Haifa, Israel
- Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano (Milan), Italy
- Ospedale Civile Monselice, Monselice, Padova, Italy
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002839 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →